| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenues | $39.6M-31.6% | $57.8M-67.2% | $176.2M-99.8% | $111.30B+0.5% | $110.70B |
| Research and development | $112.7M+1.0% | $111.5M-52.4% | $234.1M-99.9% | $249.90B+8.3% | $230.82B |
| General and administrative | $34.9M-22.0% | $44.7M-26.9% | $61.2M-99.9% | $62.68B-0.8% | $63.22B |
| Impairment of long-lived assets | $13.2M+139.7% | $5.5M-91.6% | $65.5M | $0 | $0 |
| Total operating expenses | $160.8M-0.6% | $161.8M-64.1% | $450.2M-99.9% | $312.58B+6.3% | $294.04B |
| Loss from operations | -$121.2M-16.6% | -$104.0M+62.1% | -$274.0M+99.9% | -$201.28B-9.8% | -$183.34B |
| Interest income | $1.3M-13.9% | $1.5M | — | — | — |
| Other (expense) income, net | -$3.6M-181.9% | $4.3M | — | — | — |
| Loss before income taxes | -$123.5M-25.9% | -$98.1M+62.7% | -$262.9M+99.9% | -$191.85B-7.8% | -$177.99B |
| Income tax benefit | -$568K-240.1% | -$167K+96.7% | -$5.1M-101.2% | $429.0M+40.2% | $306.0M |
| Net loss | -$122.9M-25.5% | -$97.9M+62.0% | -$257.8M+99.9% | -$192.28B-7.8% | -$178.30B |
| Basic net loss per share (in dollars per share) | -$440.00+10.2% | -$490.00+66.9% | -$1480.00-18.4% | -$1250.00-1.6% | -$1230.00 |
| Diluted net loss per share (in dollars per share) | -$440.00+10.2% | -$490.00+66.9% | -$1480.00-18.4% | -$1250.00-1.6% | -$1230.00 |
| Shares used in computing basic net loss per share (in shares) | $280193000.00+38.9% | $201699000.00+15.6% | $174444000.00+13.0% | $154345000.00+6.8% | $144568000.00 |
| Shares used in computing diluted net loss per share (in shares) | $280193000.00+38.9% | $201699000.00+15.6% | $174444000.00+13.0% | $154345000.00+6.8% | $144568000.00 |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.